These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 5099673)
1. Glyoxalase inhibitors. A possible approach to anticancer agents. Vince R; Daluge S J Med Chem; 1971 Jan; 14(1):35-7. PubMed ID: 5099673 [No Abstract] [Full Text] [Related]
2. Cytotoxicity assays with L1210 cells in vitro: comparison with L1210 in vivo and KB cells in vitro. Thayer PS; Himmelfarb P; Watts GL Cancer Chemother Rep 2; 1971 Apr; 2(1):1-25. PubMed ID: 5105747 [No Abstract] [Full Text] [Related]
3. Inhibition of glyoxalase I: a possible transition-state analogue inhibitor approach to potential antineoplastic agents? Douglas KT; Nadvi IN FEBS Lett; 1979 Oct; 106(2):393-6. PubMed ID: 499526 [No Abstract] [Full Text] [Related]
4. Synthesis and evaluation of alpha-hydroxythiol esters as antitumor agents and glyoxalase I inhibitors. Hall SS; Doweyko LM; Doweyko AM; Zilenovski JS J Med Chem; 1977 Oct; 20(10):1239-42. PubMed ID: 903914 [TBL] [Abstract][Full Text] [Related]
5. Potential carcinolytic agents. VII. Substituted bis(2-methanesulfonoxyethyl)anilines. Papanastassiou ZB; Bruni RJ; Estes PB; Wodinsky I J Med Chem; 1969 Sep; 12(5):825-8. PubMed ID: 5818089 [No Abstract] [Full Text] [Related]
6. Synthesis of potential anticancer agents. 38. N-Nitrosoureas. 4. Further synthesis and evaluation of haloethyl derivatives. Johnston TP; McCaleb GS; Opliger PS; Laster WR; Montgomery JA J Med Chem; 1971 Jul; 14(17):600-14. PubMed ID: 5170822 [No Abstract] [Full Text] [Related]
7. Further studies on liver glyoxalase I and glyoxalase II. Activity in mice bearing sarcoma 180 and L1210 leukemia. Winter R; Piskorska D; Jerzykowski T Neoplasma; 1978; 25(4):465-70. PubMed ID: 692805 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of cancer growth in mice by a normal metabolite. Apple MA; Greenberg DM Life Sci; 1967 Oct; 6(20):2157-60. PubMed ID: 6072766 [No Abstract] [Full Text] [Related]
9. Antitumor activity and mode of action of 2-thio-6-azauridine (NSC-146268) on L1210 leukemia. Li LH; Neil GL; Moxley TE; Olin EJ Cancer Chemother Rep; 1974; 58(3):345-52. PubMed ID: 4858297 [No Abstract] [Full Text] [Related]
12. Synthesis and antitumor evaluation of the presumed cytotoxic metabolites of spermine and N,N'-bis(3-aminopropyl)nonane-1,9-diamine. Israel M; Zoll EC; Muhammad N; Modest EJ J Med Chem; 1973 Jan; 16(1):1-5. PubMed ID: 4682195 [No Abstract] [Full Text] [Related]
13. Analogs of 5'-deoxy-5'-(methylthio)adenosine. Montgomery JA; Shortnacy AT; Thomas HJ J Med Chem; 1974 Nov; 17(11):1197-207. PubMed ID: 4412000 [No Abstract] [Full Text] [Related]
14. Spleen colony studies of leukemia L1210. IV. Sensitivities of L1210 and L1210/6-MP to triazenoimidazolecarboxamides--a preliminary report. Wodinsky I; Swiniarski J; Kensler CJ Cancer Chemother Rep; 1968 Apr; 52(3):393-8. PubMed ID: 5670721 [No Abstract] [Full Text] [Related]
18. Studies on methylglyoxal. II. Changes of methylglyoxal level accompanying the changes of glyoxalase I and II activities in mice bearing L1210 leukemia and sarcoma 180. Matsuura T; Owada K; Sano M; Saito S; Tomita I; Ikekawa T Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):2926-30. PubMed ID: 3769094 [No Abstract] [Full Text] [Related]